These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33155419)

  • 1. Six-step etoposide desensitization protocol: A pediatric, adolescent, and young adult case series.
    Stockton W; Lam F; Nguyen T; Nguyen T; Kirov I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28795. PubMed ID: 33155419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etoposide desensitization. A case report].
    Alvarez Cardona A; Hernández Nieto L; Pérez Gómez M; Pedroza Meléndez A; Huerta López JG
    Rev Alerg Mex; 2010; 57(1):33-6. PubMed ID: 20857627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful rapid desensitization to intravenous etoposide using a 14-step protocol.
    Garcia Escallon S; Muniyappa PK; Subramanian S
    J Allergy Clin Immunol Pract; 2015; 3(4):627-8. PubMed ID: 25634221
    [No Abstract]   [Full Text] [Related]  

  • 4. A case series of pediatric oncology patients undergoing successful rapid etoposide desensitization.
    Wright TE; Shah MD; Rider NL; Porea TJ; Musick MA; Miller J; Daves M; Foster JH; Anvari S
    Pediatr Allergy Immunol; 2019 Aug; 30(5):579-582. PubMed ID: 30963632
    [No Abstract]   [Full Text] [Related]  

  • 5. Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies.
    Stockton WM; Nguyen T; Zhang L; Dowling TC
    J Oncol Pharm Pract; 2020 Mar; 26(2):397-405. PubMed ID: 31315549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: Six-step etoposide desensitization protocol: A pediatric, adolescent, and young adult case series.
    Diebert N; Roh L; Fernández KS
    Pediatr Blood Cancer; 2021 May; 68(5):e28881. PubMed ID: 33381884
    [No Abstract]   [Full Text] [Related]  

  • 7. A pediatric desensitization protocol for etoposide.
    Martinez N; Miyasaki A; Roh L; Koole W; Fernandez KS
    Am J Health Syst Pharm; 2020 Feb; 77(4):277-281. PubMed ID: 32031209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shortened docetaxel desensitization protocol for use in special cases.
    Zirbs M; Seifert F; Zink A; Ring J; Brockow K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):391-3. PubMed ID: 22339786
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting success of desensitization after pegaspargase allergy.
    Swanson HD; Panetta JC; Barker PJ; Liu Y; Inaba H; Relling MV; Pui CH; Karol SE
    Blood; 2020 Jan; 135(1):71-75. PubMed ID: 31750901
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful Desensitization to Etoposide in a Preschool Pediatric Patient.
    Kulhas Celik I; Guvenir H; Buyuktiryaki B; Dibek Misirlioglu E; Ozyoruk D; Toyran M
    J Investig Allergol Clin Immunol; 2018 Oct; 28(5):363-364. PubMed ID: 30350799
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Desensitization Protocol for Hypersensitivity Reaction Caused by Irinotecan in a Patient With Metastatic Colorectal Cancer.
    Abu-Amna M; Hassoun G; Hadad S; Haim N; Bar-Sela G
    Clin Colorectal Cancer; 2015 Dec; 14(4):e49-51. PubMed ID: 26051444
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide hypersensitivity.
    Yersal O; Barutca S; Meydan N
    J BUON; 2013; 18(2):547-8. PubMed ID: 23818380
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypersensitivity reactions to etoposide.
    Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH
    Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.
    Alonso Martinez S; Segal NH; Cercek A; Yaeger R; Stadler Z; Kemeny NE; Nusrat M; Shahrokni A; Connell L; Saltz LB
    Clin Colorectal Cancer; 2022 Jun; 21(2):149-153. PubMed ID: 35125319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.
    Reeves DJ; Callahan MJ; Sutton GP
    Am J Health Syst Pharm; 2012 Mar; 69(6):499-503. PubMed ID: 22382481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol.
    Wong JT; Ripple RE; MacLean JA; Marks DR; Bloch KJ
    J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):189-94. PubMed ID: 7914900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
    Dodgshun AJ; Hansford JR; Cole T; Choo S; Sullivan MJ
    Pediatr Blood Cancer; 2016 Jan; 63(1):17-20. PubMed ID: 26207610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.